Shockwaves, laser and sterile-water needling for chronic pain: a 2025 perspective · Lab study · 2025
How is shockwave thought to work, and could it be combined with other treatments?
This perspective explains how shockwave is thought to act, mostly from lab and animal research, and proposes combining it with laser and sterile-water injections, a plan not yet tested in trials. For shoulder calcium deposits, the authors report that needling with rinsing did better than shockwave in the studies cited.
Explores how shockwave works- treatments discussed: shockwave, laser and sterile-water injections
- 3
- references cited for shockwave, mostly reviews
- 9
- year published
- 2025
Good to know: Most of the injection evidence comes from the authors’ own studies.
Chen CPC, Suputtitada A Biomedicines, 2025 · Read the paper ↗
The treatment
- Shockwave parameters described
- Focused or radial pulses at 0.05–0.3 mJ/mm², 1,500–3,000 per session, 1–4 sessions at weekly intervals. No device, frequency, pressure, target site or condition-specific regimen is given.
- Other components
- Laser: pulsed Nd:YAG 1,064 nm, peak power about 10 kW in Section 2.2.1 and 2–10 kW elsewhere, 8–12 sessions, often with supervised exercise. Sterile water: 2.5 mL plus 0.5 mL of 1% lidocaine per site (Table 1, Box 1), 3 mL (Section 8) or 2–5 mL (Section 4.3.3), 1–4 sessions. Proposed mixture: 0.5 mL of 1% lidocaine, 1 mL of 5% dextrose and 1.5 mL of sterile water per site.
- Proposed sequence (authors' opinion)
- Needling with sterile water first, then shockwaves if dysfunction persists, then laser; or sterile water alone when, in the authors' framework, the patient's own healing capacity is considered adequate. Section 8 states that sequential application enhances efficacy, without a cited trial.
Who took part
No new patients. Shockwave evidence comes mostly from earlier reviews of tendon, heel, shoulder and knee conditions, and from lab and animal research.
Side effects
Mild redness, swelling or soreness that settles in a day or two; rarely, small skin bleeds or brief tingling.
All the numbers and the full appraisal
What the full paper reports.
No new patient cohort. Shockwave evidence is cited as nine references, mostly systematic reviews and meta-analyses of tendinopathies, plantar fasciitis, calcific shoulder tendinitis and knee osteoarthritis, plus four reviews of laboratory and animal mechanisms. Sterile-water evidence rests mainly on the authors' own cohorts in lumbar spinal stenosis and facet joint syndrome, described as more than 4,000 patients.
Proposed shockwave mechanisms1 reported outcome
Proposed shockwave mechanisms
Qualitative finding
Mechanical stress, micro-cavitation and fluid micro-jets are said to activate mechanosensitive channels and MAPK/ERK and Wnt–β-catenin signalling, raise VEGF, eNOS and MMP-2/9, lower TGF-β1 and reduce substance P and CGRP, supporting new blood vessels, matrix remodelling and less peripheral sensitization.
Analysis details and source
Stated as established, but cited to four reviews of mostly cell and animal work.
Shockwave clinical evidence and certainty1 reported outcome
Shockwave clinical evidence and certainty
Qualitative finding
The authors state that recent meta-analyses confirm significant pain and function improvements in osteoarthritis, plantar fasciitis and calcific tendinopathy, and that imaging shows resolution of calcific deposits. They rate the evidence "B–A–" with consistent outcomes and moderate heterogeneity. Overall risk of bias is described as low to moderate, with concerns from lack of blinding and varied protocols.
Analysis details and source
No effect sizes, intervals, numbers of trials or participants are given for shockwaves. The grade is the authors' own and is not a GRADE category; one of the cited meta-analyses is held in this library for unresolved data problems.
Needling with lavage versus shockwaves in calcific shoulder tendinopathy1 reported outcome
Needling with lavage versus shockwaves in calcific shoulder tendinopathy
Qualitative finding
In rotator cuff calcific tendinopathy, ultrasound-guided needling with lavage is reported to have outperformed shockwaves for both pain reduction and deposit clearance in randomized trials and meta-analyses.
Analysis details and source
An unfavourable comparison for shockwaves reported in the perspective, without numbers. It is cited to references 39–40 in Section 2.3.3 but to references 40 and 42 (a knee saline meta-analysis) in Section 5. By its title, the cited randomized trial (reference 39) combined needling with a subacromial corticosteroid injection, a co-intervention the perspective does not mention.
Certainty grades across the article1 reported outcome
Certainty grades across the article
Qualitative finding
Shockwaves are "B–A–" throughout. Laser is "B" in Table 3 and Section 7 but "B–A–" in the abstract, Section 6 and the conclusions. Sterile water is upgraded from "B" to "B–A–" on the basis of the authors' own cohorts (Newcastle–Ottawa 9/10), a three-arm randomized trial and saline meta-analyses.
Analysis details and source
The randomized trial as described compared dextrose injection into the multifidus, medial branch block and intra-articular facet injection, with no sterile-water arm, while Table 1 calls it a trial against prolotherapy or lidocaine. The table note says ratings were derived from high, moderate, low and very low, but letter grades are printed instead.
Proposed combination and sequence1 reported outcome
Proposed combination and sequence
Qualitative finding
The authors propose a "regenerative triad" (sterile-water needling, then shockwaves, then laser) and a triple-component injection, and ask professional societies to include the triad in guidelines. They state that randomized validation of the injection is still needed.
Analysis details and source
Opinion based on the authors' clinical experience; no cited study tests the triad, its order or the mixture. Reported to describe the source, not as a recommendation.
How treatment was delivered
Focused or radial pulses at 0.05–0.3 mJ/mm², 1,500–3,000 per session, 1–4 sessions at weekly intervals. No device, frequency, pressure, target site or condition-specific regimen is given.
Laser: pulsed Nd:YAG 1,064 nm, peak power about 10 kW in Section 2.2.1 and 2–10 kW elsewhere, 8–12 sessions, often with supervised exercise. Sterile water: 2.5 mL plus 0.5 mL of 1% lidocaine per site (Table 1, Box 1), 3 mL (Section 8) or 2–5 mL (Section 4.3.3), 1–4 sessions. Proposed mixture: 0.5 mL of 1% lidocaine, 1 mL of 5% dextrose and 1.5 mL of sterile water per site.
Needling with sterile water first, then shockwaves if dysfunction persists, then laser; or sterile water alone when, in the authors' framework, the patient's own healing capacity is considered adequate. Section 8 states that sequential application enhances efficacy, without a cited trial.
No harms data are extracted from the cited studies. For shockwaves the authors describe mild redness, swelling or soreness resolving within 24–48 hours and rare petechiae or transient tingling, and list contraindications (infection or cancer at the site, pregnancy, uncontrolled bleeding disorders, nearby gas-filled organs). Their statement that energies up to 0.3 mJ/mm² cause only reversible microvascular changes cites clinical meta-analyses rather than histology or MRI studies.
Author-stated: protocol heterogeneity, varied outcome measures and difficulty blinding physical treatments; few and small randomized trials for sterile water, so causality is not yet firmly established; incomplete validation of biomarkers and imaging correlates; no standardized international protocols; limited long-term comparative data.
Extractor: the search is described only by databases, keywords and years; there are no selection criteria, study list or per-study appraisal, risk of bias is summarized per treatment, RoB 2.0 is listed for meta-analyses, and the "B–A–" letter grades are not GRADE categories. The authors' own studies are included as "representative high-quality" evidence.
Internal inconsistencies: laser certainty "B" (Table 3, Section 7) versus "B–A–" (abstract, Section 6, conclusions); saline described as not inert (Section 2.3.3) and as biologically inert (Section 4.4); sterile-water volumes of 2.5, 3 and 2–5 mL; the facet-syndrome trial described without a sterile-water arm but listed as sterile-water evidence; the lavage-versus-shockwave claim cited to different references in Sections 2.3.3 and 5.
Extractor: mechanism claims are stated as established and the safety claim about reversible microvascular effects cites clinical meta-analyses; "sequential application enhances efficacy" is asserted without a trial. One cited shockwave meta-analysis (Majidi 2024) is held in this library for unresolved problems with its pooled data. Funding: National Science and Technology Council of Taiwan (NSTC114-2314-B182-021-MY2). Conflicts: none declared, although the sterile-water evidence the authors grade and upgrade comes almost entirely from their own studies (two cohorts, a comparative study, the randomized trial and one saline meta-analysis; references 31–33, 38 and 41). No device-maker ties are reported.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- Author-stated: protocol heterogeneity, varied outcome measures and difficulty blinding physical treatments; few and small randomized trials for sterile water, so causality is not yet firmly established; incomplete validation of biomarkers and imaging correlates; no standardized international protocols; limited long-term comparative data.
- Extractor: the search is described only by databases, keywords and years; there are no selection criteria, study list or per-study appraisal, risk of bias is summarized per treatment, RoB 2.0 is listed for meta-analyses, and the "B–A–" letter grades are not GRADE categories. The authors' own studies are included as "representative high-quality" evidence.
- Internal inconsistencies: laser certainty "B" (Table 3, Section 7) versus "B–A–" (abstract, Section 6, conclusions); saline described as not inert (Section 2.3.3) and as biologically inert (Section 4.4); sterile-water volumes of 2.5, 3 and 2–5 mL; the facet-syndrome trial described without a sterile-water arm but listed as sterile-water evidence; the lavage-versus-shockwave claim cited to different references in Sections 2.3.3 and 5.
- Extractor: mechanism claims are stated as established and the safety claim about reversible microvascular effects cites clinical meta-analyses; "sequential application enhances efficacy" is asserted without a trial. One cited shockwave meta-analysis (Majidi 2024) is held in this library for unresolved problems with its pooled data. Funding: National Science and Technology Council of Taiwan (NSTC114-2314-B182-021-MY2). Conflicts: none declared, although the sterile-water evidence the authors grade and upgrade comes almost entirely from their own studies (two cohorts, a comparative study, the randomized trial and one saline meta-analysis; references 31–33, 38 and 41). No device-maker ties are reported.
Source-linked critical reading
Perspective (narrative review with author-assigned certainty grades)
Technical source record
Complete local PDF read (16 pages), including all sections, Tables 1–3 and Box 1 on the page images, funding, conflict statement and references. Cited studies were not read.
This perspective explains how shockwaves are thought to act on tissue, mostly from laboratory and animal research, and argues for combining them with laser therapy and sterile-water injections. That combination and its order have not been tested, the certainty ratings are the authors' own, and, for shoulder calcium deposits, the authors report that needling with lavage did better than shockwaves in the studies they cite.
What mechanisms and clinical evidence do the authors put forward for shockwave therapy, high-intensity laser therapy and ultrasound-guided needling with sterile water, and for combining them as a drug-free approach to chronic musculoskeletal pain?
Perspective article. The authors searched PubMed, Scopus and Web of Science by keyword for 2020–2025 publications, but report no selection criteria, study flow, number of included studies or per-study results. Risk of bias (RoB 2.0, Newcastle–Ottawa) and certainty ratings are summarized only per treatment. The authors' own sterile-water studies were included. No new data.
No new patient cohort. Shockwave evidence is cited as nine references, mostly systematic reviews and meta-analyses of tendinopathies, plantar fasciitis, calcific shoulder tendinitis and knee osteoarthritis, plus four reviews of laboratory and animal mechanisms. Sterile-water evidence rests mainly on the authors' own cohorts in lumbar spinal stenosis and facet joint syndrome, described as more than 4,000 patients.
Shockwaves are described as focused or radial pulses at 0.05–0.3 mJ/mm², 1,500–3,000 per session, 1–4 sessions at weekly intervals, without device or condition detail. Laser: pulsed Nd:YAG 1,064 nm, 2–10 kW peak power, 8–12 sessions. Sterile-water injection volume is 2.5 mL plus 0.5 mL of 1% lidocaine per site in Table 1 and Box 1, 3 mL in Section 8, and 2–5 mL in Section 4.3.3. The order needling, then shockwaves, then laser, and a lidocaine–dextrose–sterile-water mixture are the authors' proposals.
The perspective makes no new comparison. Cited comparisons include shockwaves versus sham or other treatments in the meta-analyses, ultrasound-guided needling with lavage versus shockwaves in calcific shoulder tendinopathy, and sterile water versus lidocaine, steroids or prolotherapy in the authors' own studies. No cited study tests the three treatments together or in the proposed order.
Pain, function, calcific-deposit resolution and imaging as described from the cited reviews, without effect sizes; certainty grades assigned by the authors. The biomarkers named (VEGF, eNOS, MMP-2/9, TGF-β1, substance P, CGRP) come from reviews of cell and animal work and were not measured here.
For shockwaves the authors describe mechanotransduction (MAPK/ERK, Wnt–β-catenin), new blood vessels, matrix remodelling and lower substance P and CGRP, citing four reviews of mostly laboratory and animal work, and rate the clinical evidence "B–A–" (moderate to high) without effect sizes. They also report that, in calcific shoulder tendinopathy, ultrasound-guided needling with lavage did better than shockwaves for pain and deposit clearance in trials and meta-analyses. The proposed sequence of the three treatments and the triple-component injection have not been tested in trials, which the authors acknowledge for the injection.
No harms data are extracted from the cited studies. For shockwaves the authors describe mild redness, swelling or soreness resolving within 24–48 hours and rare petechiae or transient tingling, and list contraindications (infection or cancer at the site, pregnancy, uncontrolled bleeding disorders, nearby gas-filled organs). Their statement that energies up to 0.3 mJ/mm² cause only reversible microvascular changes cites clinical meta-analyses rather than histology or MRI studies.
Keyword search without selection criteria, study list or per-study appraisal; risk of bias and certainty are given per treatment, RoB 2.0 is applied to meta-analyses, and the letter grades used ("B–A–") are not GRADE categories. Laser certainty is "B" in Table 3 and Section 7 but "B–A–" in the abstract, Section 6 and the conclusions. The upgrade for sterile water rests on the authors' own cohorts, a randomized trial whose described arms include no sterile water, and saline meta-analyses; saline is called not inert in one section and biologically inert in another. One cited shockwave meta-analysis (Majidi 2024) is held in this library because of unresolved problems with its pooled data. Funding: National Science and Technology Council of Taiwan; no conflicts declared, although the sterile-water evidence the authors grade and upgrade comes almost entirely from their own studies (two cohorts, a comparative study, the randomized trial and one saline meta-analysis).
Shows how proponents place shockwaves within a drug-free, "regenerative" model of chronic pain. It does not estimate how much shockwaves help any condition, and its proposed sequence of treatments and injection mixture are untested.
Trials comparing the proposed sequence or combination with each component alone and with usual care; a reproducible systematic review with per-study appraisal; and human studies linking the proposed biomarkers to patient outcomes.
Read the original article.
Regenerative and Drug-Free Strategies for Chronic Musculoskeletal Pain: An Evidence-Based Perspective on Shockwave Therapy, High-Intensity Laser Therapy and Ultrasound-Guided Mechanical Needling with Sterile Water Injection.
Chen CPC, Suputtitada A. · Biomedicines · 2025
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →